This session will offer a summary of the most relevant abstracts from the Palliative track:
71 - Optimized Survival Evaluation to Guide Bone Metastases Management:?Developing an Improved Statistical Approach
73 - Phase III Multi-Center, Prospective Randomized Trial Comparing High Dose Single Fraction Radiotherapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Human Cancer
74 - Celiac Plexus Radiosurgery, a new modality for cancer pain management - final results of a phase II clinical trial
5 - Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of A Randomized Trial
1013 - Prescription of Evidence-Based Single Fraction Radiation Therapy for Bone Metastases Can be Increased in a Meaningful and Sustained Way on a Population Level Using Quality Assurance Data
1016 - Variation in Use of Palliative Radiation in Lung Cancer Patients with Bone Metastases by Health Care Market
The asset you are trying to access is locked. Please enter your access key to unlock.